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Purpose: Long-term application of glucocorticoids as a treatment for conditions such as allergy, autoimmune diseases,
and  transplantation  presents  a  high  risk  of  development  of  steroid-induced  cataract.  The  presence  of  a  functional
glucocorticoid receptor (GR) in human and rat lens epithelial cells suggests a direct and specific targeting of these lens
cells by glucocorticoids. One important cytoskeletal protein in lens epithelial cells is vimentin, which plays an important
role in maintaining the normal lens morphology and function. Previous studies have shown that vimentin is involved in
signal transduction, changes in cell structure and differentiation, and apoptosis. Based on a model of steroid-induced
cataract from our previous study, the present study focuses on whether changes in vimentin can be induced in vitro through
specific GR activation in glucocorticoid-induced cataracts of the rat lens.
Methods: Clear rat lenses, cultured in vitro, were treated with or without dexamethasone (Dex) or RU486 (a glucocorticoid
receptor antagonist). Lenses were cultured for 7 days at 37 °C under 5% CO2, and were observed daily with an inverted
microscope.  Changes  in  morphology  were  followed  by  Hematoxylin-eosin  (HE)  staining,  transmission  electron
microscopy, and immunohistochemistry. The expression of vimentin mRNA and protein was examined by reverse
transcription polymerase chain reaction (RT–PCR) and western blot analysis, respectively, in the capsule-epithelium and
fiber tissue of the lenses.
Results: Opacity was obviously present at day 7 in the Dex group. The lenses of the untreated group and the RU486+Dex
group remained transparent throughout the incubation. Electron microscopy showed an orderly arrangement of fiber cells
and normal cell junctions in the control group and the RU486+Dex group. However, in the Dex group, fiber cells were
disarranged and the cell-cell junctions exhibited lacunae. The expression of vimentin protein in the lens capsule-epithelium
and fiber tissue decreased in the Dex-treated group, but normal expression of vimentin mRNA was maintained.
Conclusions: These results suggest that the GR-mediated reduction in vimentin may be involved in the formation of
steroid-induced cataract.
Glucocorticoids are steroid hormones that are commonly
employed  as  treatments  for  conditions  such  as  allergy,
autoimmune diseases, and transplantation. One established
complication  and  side  effect  of  prolonged  glucocorticoid
therapy  is  the  formation  of  posterior  subcapsular  cataract
characterized by nucleated epithelial cells in the posterior
region  of  the  lens  [1-8].  The  exact  mechanism  of
glucocorticoid cataract formation is still unknown.
Glucocorticoids have been proposed to act on the lens
through mechanisms involving binding of glucocorticoids to
the hepatic glucocorticoid receptor (GR) [9-13], non-specific
glucocorticoid binding in the lens [14-16], and binding to a
membrane  receptor  [17].  Glucocorticoids  have  also  been
demonstrated  in  the  aqueous  humor  [18,19].  Importantly,
recent studies have provided evidence suggesting that rat and
human lens epithelial cells contain the classic active GR,
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which  verified  a  direct  and  specific  mechanism  of  action
[20-22], although this conclusion may not be valid in other
species [16]. Glucocorticoids may also indirectly affect the
lens  through  responses  of  other  cells  within  the  ocular
compartment and/or through effects on cells at more remote
locations.  These  remote  effects  could  then  modulate  the
intraocular levels of growth factors that normally control lens
development and homeostasis [23].
Dexamethasone, one of the glucocorticoids, has a great
affinity for the GR [24-26]. It is interesting to note that a high-
dose prolonged dexamethasone (Dex) treatment of the rat lens
resulted in a decrease in expression of cadherin protein, which
is involved in cell adhesion [27]. Our recent study also showed
that Dex treatment of rat lens resulted in a reduction in the
activity and the protein and mRNA levels of the Na+,K+-
ATPase, an important transport protein in the lens [28]. This
finding  raised  the  question  whether  glucocorticoids  can
induce changes in cytoskeletal proteins involved in cataract
formation through the specific GR activation.
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32Vimentin  is  an  important  cytoskeletal  protein  in  the
epithelial cells of the lens, where it aids in maintaining normal
lens morphology and function [29]. It is a highly conserved
type III intermediate filament and is widely distributed in
mesenchymal  tissue,  including  the  eye  lens.  Vimentin
displays a typical tripartite domain structure with a central α-
helical  rod-domain  flanked  by  non-helical  amino-  and  C-
terminal domains [30]. The vimentin network is present in
both epithelial cells and some fiber cells of the lens. Fiber cells
are vimentin positive up to a specific point 2–3 mm in from
the lens capsule, after which the vimentin signal is drastically
reduced [31]. However, vimentin appears to be absent from
the older fiber cells, as indicated by both biochemical and
immunocytochemical tests [32,33].
Recent evidence has shown that vimentin expression is
related  to  glucocorticoid  and  its  receptor.  Vimentin
determines cytoplasmic accumulation of the glucocorticoid
receptor [34]. Oral steroid therapy has been shown to inhibit
vimentin  expression  in  densely  packed  spindle  cells  of
Kaposiform haemangioendothelioma on the conjunctiva of
the  upper  eyelid  [35].  Dexamethasone  prevents  vimentin
expression  in  the  rabbit  basilar  artery  after  subarachnoid
hemorrhage [36]. Overexpression of the chicken vimentin
transgene  in  the  mouse  inhibits  normal  lens  fiber  cell
differentiation and leads to cataract formation, suggesting that
changes in vimentin expression are part of the mechanism
underlying cataract formation [37,38].
Therefore, vimentin may interfere directly or indirectly
with the proper cell differentiation processes in the lens, so
that correct regulation of vimentin expression is essential for
optical clarity. Changes in vimentin may affect the function
of  lens  epithelial  cells,  which  may  further  affect  the
transparency  of  the  lens.  This  study  evaluated  whether
glucocorticoid  treatment  can  induce  changes  in  vimentin
through  specific  GR  activation  in  glucocorticoid-induced
cataracts of the rat lens.
METHODS
Materials: Dexamethasone, RU486, Dulbecco’s MEM, and
BSA were obtained from Sigma Chemical Company (Santa
Clara, CA). Sprague-Dawley rats were provided by Animal
Laboratories  of  the  Fourth  Military  Medical  University
(Xi'an,  China).  Primary  vimentin  antibody  was  purchased
from  Epitomics  Company  (Burlingame,  CA).  Primary  β-
Actin antibody was obtained from Sigma Chemical Company.
All other chemicals and solvents were of analytical grade and
were obtained from local companies.
Lens  incubation  and  separation:  All  animal  procedures
conformed to the ARVO Statement for the use of Animals in
Ophthalmic and Vision Research. For rat lens culture, eyes
from three week old Sprague-Dawley female rats weighing
40–50 g were enucleated and placed in Dulbecco’s MEM
(Sigma) containing BSA (Sigma), and antibiotic solution (100
U/ ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml
amphotericin B). The conditions for rat lens culture were as
reported previously [27,39]. The eyes were opened posteriorly
to avoid damaging the lens and pressure was applied to the
anterior segment to expel the lens using plastic-coated forceps
and fine scissors. Lenses were immediately transferred into
culture medium, which was changed daily. Approximately 24
h after the preparation of organ cultures, clear lenses were
selected, and dexamethasone (Sigma) was added to a final
concentration of 5 µM [40]. RU486 (Sigma), a GR antagonist,
and dexamethasone were added to the culture medium at a
final  concentration  of  5  µM  [27]  to  block  glucocorticoid
signaling. Lenses were cultured for 7 days at 37 °C under 5%
CO2, and were observed daily under a stereomicroscope and
photographed. In a preliminary study, the effect of RU486
itself on the lens transparency was checked during 7 days
incubation.
At the end of the culture period, the capsule-epithelium
and the fiber tissue of lenses were removed by gently making
an incision near the equator of the lens and peeling back the
capsule-epithelium  using  fine  forceps  [41].  To  slow
proteolysis and mRNA breakdown, tissues were kept chilled
during  dissection.  The  separated  lens  tissues  were  frozen
immediately in liquid nitrogen and stored at –70 °C.
Observation of lens transparency: Whole rat lenses cultured
in vitro were randomly divided into three groups: control
group  (DMEM),  dexamethasone  group  (DMEM+5µM
dexamethasone),  and  RU486+Dex  group  (DMEM+5µM
dexamethasone+5µM  RU486).  Following  7  days  of
incubation,  lenses  were  photographed  daily  with  a
stereomicroscope and graded for the development of opacity
on a scale from 0 to 4 according to Mathur’s method, where
5 stages were given according to the lens clarity [27,40,42].
Lens examination by electron microscopy: Two lenses from
each group were examined by electron microscopy at day 7.
Lenses were lightly fixed in 2.5% glutaraldehyde in 0.1M
sodium phosphate buffer, pH 7.4, for 1.5 h at 4 °C. They were
then fixed in glutaraldehyde/phosphate buffer overnight at
4 °C. After washing with phosphate buffer, the lenses were
postfixed in 2% OsO4 in phosphate buffer for 1 h in an ice
bath, rinsed with three changes of prechilled buffer and finally
with distilled water. They were then stained with 2% aqueous
uranyl acetate for 1 h in the dark. The lenses were dehydrated
with increasing concentration (70%–100%) of ethanol and
infiltrated with a mixture of propylene oxide/Epon-Aradite
(Embed-812; EMS, Washington, PA) and embedded in Epon-
Araldite. Ultrathin tissue sections (50–60 nm in thickness)
were stained with 2% aqueous uranyl acetate for 30 min at
60 °C, rinsed with methanol and water, and stained with 0.3%
lead citrate for 10 min at 60 °C. Sections were examined with
a JEM-100SX (JEOL, Tokyo, Japan) electron microscope at
80 kV and at 10,000 fold magnification.
Analysis of vimentin by western blotting: The lens capsule-
epithelium and fiber tissues were homogenized separately in
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331 ml of extraction buffer composed of 6 mM phosphate buffer
(pH 7.2) containing 100 mM KCl, 5 mM MgCl2, 10 mM 2-
mercaptoethanol plus 1 mM EGTA, 1 mM EDTA, 10 µM N-
ethylmaleimide,  200  µM  phenylmethylsulphonyl  fluoride,
and 5 µM E64 to prevent proteolysis during preparation. The
homogenate  was  centrifuged  at  12,000×  g  for  30  min  to
separate the soluble from insoluble proteins. The pellet was
washed three times by resuspension in 1 ml extraction buffer
and centrifugation. The washed insoluble pellet from the lens
homogenate  was  separated  into  urea-soluble  and  urea-
insoluble fractions by extraction in 8 M urea followed by
centrifugation (12 000× g for 30 min). The final supernatant
of the urea-soluble fraction was resuspended in extraction
buffer, frozen in liquid nitrogen, and stored at −70 °C.
Proteins of the urea-soluble fraction of lens samples were
separated  by  electrophoresis  on  a  12%  sodium  dodecyl
sulfate-polyacrylamide gel using the Laemmli buffer system.
Lens  membrane  protein  samples  (80  µg)  were  applied  to
specified  lanes  of  the  gel.  The  separated  proteins  were
transferred electrophoretically to nitrocellullose at 100 V for
60 min in transfer buffer containing Tris (25 mM), glycine
(192 mM), and 10% methanol at pH 8.3. Blots were incubated
for 2 h at room temperature in TBS containing 0.1% Tween-20
(TBST) and 5% nonfat dried milk. They were then incubated
overnight  at  4  °C  with  the  primary  vimentin  antibody
(Epitomics), diluted in TBST, according to the manufacturer’s
recommendations. Rabbit monoclonal vimentin and mouse
monoclonal  anti-β-Actin  (Sigma)  antibodies  were  used  to
detect the corresponding proteins. After washing three times
with  TBST,  membranes  were  incubated  for  1  h  with
horseradish  peroxidase-coupled  secondary  antibodies
(1:1,000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA)
at room temperature. Images were detected with the ECL kit
(Pierce, Rockford, IL). The scanned images were quantified
using  Kodak  Digital  Science  one-dimensional  software
(Eastman Kodak Co., Rochester, NY).
HE stain and immunohistochemistry analysis for vimentin:
Flat  preparations  of  the  equatorial  capsule  (containing
adherent epithelial cells) were prepared by bisecting the lens.
These  were  fixed  for  24  h  at  room  temperature  in  4%
paraformaldehyde  in  PBS.  After  fixation  and  paraffin-
embedding, 5 µm thick tissue sections were obtained, and then
were dehydrated with a graded series of increasing ethanol
concentrations. The samples were embedded in Epon mixture.
For each sample, the section was stained with hematoxylin-
eosin.  For  immunohistochemistry  analysis,  the  sample
sections were blocked in PBS containing 5% goat serum and
0.1% Triton X-100, and incubated overnight with monoclonal
anti-vimentin (Epitomics) at a dilution of 1:200. Samples were
then incubated for 1 h with rhodamine-conjugated goat anti-
rabbit IgG antibody (Zymed, San Diego, CA) at a dilution of
1:500.  Histological  images  were  photographed  with  a
microscope (BX50; Olympus, Tokyo, Japan) and a digital
camera (Nikon, Tokyo, Japan).
Reverse transcription polymerase chain reaction (RT–PCR)
analysis: Total RNA was prepared from the lens capsule-
epithelium and fiber tissue with extraction reagent (Trizol;
Invitrogen, Carlsbad, CA). Total RNA (2 µg) was used for
reverse  transcription  with  reverse  transcriptase.  PCR
amplification was performed with reverse-transcribed DNA,
10 µM specific primers, 0.2 mM dNTP, and 1 mM magnesium
chloride.  The  reaction  was  performed  for  28  cycles  of
denaturation at 95 °C for 20 s, annealing at 54 °C for 20 s, and
extension at 72 °C for 20 s. The PCR primer sequences and
the sizes of the amplified products for each cDNA were as
follows:  vimentin,  5′-GCA  AAG  CAG  GAG  TCA  AAC
GA-3′ and 5′-CGT TTC GTC CTC AGT TTG CT-3′, 378 bp;
and β-actin, 5′-AGG CCA ACC GCG AAG ATG ACC-3′ and
5′-GAA GTC CAG GGC GAC GTA GCA C-3′, 350 bp.
Statistical analysis: The statistical significance of differences
was assessed with Kruskal–Wallis H test using SPSS (Version
12.0)  software.  Results  of  opacification  are  presented  as
median values and range.
RESULTS
Steroid-induced opacity in cultured lens and inhibition by
RU486: To observe the effects of glucocorticoid on the lens,
as previously reported [27,28,40], rat lenses were isolated and
treated in organ culture with dexamethasone. In this study,
mist-like opacity of the lenses was observed as early as 5 days
in the dexamethasone (Dex) group (Table1). The opacity was
more obvious at day 7. The lenses of the untreated group and
the  RU486+Dex  group  remained  transparent  during  the
incubation period (Table1).
In  preliminary  experiments,  the  rat  lenses  remained
transparent throughout the incubation period in the presence
of 5 µM RU486 without Dex (data not shown), indicating that
5 µM RU486 itself did not affect the transparency and the
metabolism of the lens. A similar result was reported in the
cultured  rat  lens  by  Lyn  et  al.  [27].  Therefore,  in  the
experiments, an RU486-only group was not included.
The  morphology  changes  of  the  cultured  lens:  HE  stain
showed an orderly arrangement of fiber cells in the control
group (Figure 1A) and the RU486+Dex group (Figure 1C).
However, in the Dex group, the regular arrangement of fiber
cells  was  disrupted  and  the  lenses  exhibited  expanded
extracellular lacunae (Figure 1B).
Ultrastructure of the cultured lens: Transmission electron
microscopy  (TEM)  showed  an  orderly  arrangement  and
normal appearance of the cell junctions in the control group
(Figure  2A)  and  the  RU486+Dex  group  (Figure  2C).
However, in the Dex group, the cell junction was disrupted
and  the  lenses  consisted  of  abnormal  cells  that  exhibited
vacuoles and expanded extracellular lacunae (Figure 2B).
Effects  of  dexamethasone  on  vimentin  protein  levels  in
cultured rat lens: We analyzed the expression of vimentin to
determine  whether  it  was  involved  in  the  observed
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34morphological  changes.  Western  blotting  showed  that
vimentin protein levels in the capsule-epithelium and fiber
tissue of the lenses were reduced in the Dex group (Figure 3,
epithelium-D, fiber-D) compared with of the lens samples of
the control group (Figure 3, epithelium-C, fiber-C) and of the
RU486+Dex group (Figure 3, epithelium-R, fiber-R).
Expression  of  vimentin  in  organ-cultured  rat  lens  by
immunohistochemistry  analysis:  Immunohistochemistry
analysis showed that in the equatorial capsule (containing
adherent epithelial cells), the levels of vimentin protein were
reduced in the Dex group (Figure 4B) compared with the
control group (Figure 4A) and the RU486+Dex group (Figure
4C).
RT–PCR  analysis:  The  expression  of  vimentin  mRNA,
determined  by  RT–PCR,  was  similar  in  the  capsule-
epithelium and fiber tissue of the lenses of all three groups
(Figure 5).
DISCUSSION
In this study, we have demonstrated that RU486 can prevent
the reduction of vimentin protein expression and the changes
in lens morphology induced by Dex. These results suggested
that it is the GR that takes part in the changes in vimentin
expression levels in the rat lens. This is the first report to
demonstrate that the cataract induced by dexamethasone is
associated with a reduced expression of vimentin protein but
not expression of vimentin mRNA.
A mist-like opacity of the lenses was observed in the Dex
group, whereas the lenses of the untreated group and the
RU486+Dex  group  remained  transparent  throughout  the
incubation  period,  indicating  that  dexamethasone-induced
lens opacification was inhibited by RU486.
Vimentin, as one of major cytoskeletal proteins in the
lens, is expressed throughout the epithelium and elongating
fiber cells of the adult mammalian lens [32,43,44]. Vimentin
protein and mRNA are more abundant in the epithelium and
in  younger  elongating  fiber  cells  with  a  life-long  lasting
TABLE 1. OPACIFICATION OF RAT LENSES ANALYZED BY OCULAR STAGING.
  IncubationGD\V
 
Groups 1 2 3 4 5 6 7
A 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0)
B 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-1)a 1 (0-1)a 1 (0-1)b
C 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0)c 0 (0-0)c 0 (0-0)d
        Lens opacification was assessed in control rat lenses or lenses treated with dexamethasone (Dex) or a combination of RU486
        and dexamethasone (Ru486+Dex). Digital image analysis and ocular staging were performed by three independent observers.
        Following 7 days of incubation, lenses in the three groups were photographed daily with a stereomicroscope and graded for the
        development of opacity on a scale from 0 to 4, according to Mathur’s method, where 5 stages were given according to the lens
        clarity (Stage 0=clear lens, stage 1=lens with mist-like opacity, stage 2=lens with visible demarcation between nuclear and
        cortical regions, stage 3=lens with light nuclear opacification, stage 4=lens with dense nuclear opacity, stage 5=whole lens
        opacity). A=Control group; B=Dex group; C=RU486+Dex group. Values are expressed as medians (range of the ocular staging).
        Statistical analysis was performed using the Kruskal–Wallis H test. ap<0.05 B versus bp<0.01 B versus A. cp<0.05 C versus B.
           dp<0.01 C versus B.
Figure 1. Morphological changes of the equatorial capsule (containing adherent epithelial cells) of the cultured rat lens. A: Control group;
B: Dex group; C: RU486+Dex group. HE, original magnification 200×. A disordered arrangement of fiber cells was induced by treatment
with dexamethasone (Dex) compared to the control. In the group treated with RU486 and Dex (RU486+Dex), no disruption was observed,
which suggested that the morphological changes induced by Dex were blocked by RU486.
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35morphology  [45].  By  conventional  immunocytochemical
approaches, vimentin has been reported to be absent from, or
at least greatly reduced in, the deeper cortical fiber cells [32,
43,44]. Our current results showed that vimentin was highly
expressed  at  both  the  protein  and  mRNA  levels  in  the
epithelium and to a lesser extent in the fiber mass of the lens,
composed of the partial cortex and nucleus.
The precise role of vimentin in the biology of the lens is
not  known.  However,  previous  studies  showed  that  the
changes of vimentin expression were involved in cataract
formation. Capetanaki et al. [37] reported that overexpression
of vimentin in transgenic mice inhibited normal fiber cell
differentiation and led to cataract formation. Vimentin could
interfere  either  directly  or  indirectly  with  the  normal  cell
differentiation  processes,so  that  correct  regulation  of
vimentin  expression  may  be  essential  for  optical  clarity.
Previous  studies  have  reported  that  changes  in  vimentin
expression were responsible for apoptosis [46-48]. Vimentin
is seemingly responsible for connecting the nucleus with the
plasma membrane [49-51] and aids in transport processes and
signal transduction. Further studies have shown that vimentin
is involved in signal transduction, changes in cell structure,
cell  differentiation,  and  apoptosis  in  lens  epithelial  cells
[52-54].  Therefore,  changes  in  vimentin  may  affect  the
function  of  lens  epithelial  cells,  leading  to  altered
transparency  of  the  lens  [55].  The  exact  mechanism  and
pathogenesis of a steroid induced cataract are still unclear.
The GR was detected in both rat and human lens via in
situ  hybridization  [20,21].  Receptor  specificity  was
determined by a specific GC antagonist, RU486.Therefore
RU486 provides a way to evaluate receptor-mediated events
in the steroid induced cataract [56,57]. It can inhibit Dex-
induced decrease in receptor activity [57,58]. In considering
the mechanism for glucocorticoid effect on the lens, it should
be noted that RU486 blocked the changes in gene expression
and  protein  metabolism  in  lens  epithelium  treated  with
dexamethasone. Previous studies have shown that the GR
present in the rat lens epithelial cells is able to bind with the
Figure 2. Morphological changes of the cultured rat lens. A: Control group; B: Dex group; C: RU486+Dex group. TEM, original magnification
120,000×). In the dexamethasone (Dex) group (B), the orderly arrangement of cell-junctions was disrupted compared with of the control group
(A). In the group treated with both RU486 and Dex (RU486+Dex; C), no disruption was observed, which suggested that the morphological
changes induced by Dex were blocked by RU486.
Figure 3. Levels of vimentin protein in rat lenses determined by western blot analysis. Vimentin protein levels in the whole lens were reduced
in the group treated with dexamethasone (Dex; epithelium-D, fiber-D) compared with the control group (epithelium-C, fiber-C) and the group
treated with Dex and RU486 (epithelium- R, fiber- R), which indicated RU486 prevented the reduced expression of vimentin protein induced
by Dex . β-Actin was used as the control for protein loading. C: Control group; D: Dex group; R: RU486+Dex group.
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36classic glucocorticoid response element (GRE) and modulate
the expression of a target gene [59,60]. In our current study,
a statistically significant decrease in the protein expression
levels of vimentin was observed under the treatment of 5 µM
dexamethasone, but not in the negative control. Furthermore,
these changes of vimentin were inhibited when the lenses were
co-treated with RU486. These results indicated that the lens
GR was responsible for glucocorticoid induced changes of
vimentin.
Glucocorticoids, which play important regulatory roles
in cellular physiology, are generally accessible to the cell
membrane through passive diffusion and are able to bind to
GR [61]. Agonist ligand binding activates the receptor by
induction  of  a  conformational  change,  resulting  in
dissociation of heat shock proteins and hyperphosphorylation
of the receptor [62]. The ligand-receptor complex translocates
to the nucleus, dimerizes, and binds to a cis-acting element,
GRE, typically present in the 5′ flanking region of the target
genes [63]. The conformational change gives the receptor-
hormone complex the ability to bind DNA and modulate the
expression  of  target  genes  [64].  DNA  microarray
hybridization  data  obtained  from  cultured  human  lens
epithelial cells exposed to glucocorticoids has indicated that
a  broad  range  of  transcripts  are  up-  or  down-regulated
compared to unexposed control cells [60,65].
Glucocorticoid treatment of human lens epithelial cells
results in activation of the GR and subsequent modulation of
target  gene  expression  via  the  mitogen  activated  protein
kinases (MAPKs) and phosphatidylinositol 3 kinase/protein
kinase  B  (PI3K)/AKT)  pathways  [60,65].  Analysis  of
microarray  data  from  primary  cultures  of  human  lens
epithelial  cells  has  suggested  that  the  glucocorticoid-GR
activation  may  affect  many  cellular  functions,  such  as
proliferation,  differentiation,  apoptosis,  survival,  or
migration, through modulation of the MAPK and PI3K/AKT
pathways [57]. Since the MAPK and PI3K/AKT pathways
have been reported to play important roles in similar cellular
functions in many cell types, including lens epithelial cells
[66,67], it is possible that the changes in modulation of these
pathways  could  lead  to  abnormal  lens  epithelial  cell
proliferation, differentiation, motility, survival, or apoptosis,
all of which have been implicated in the formation of a steroid-
induced  cataract.  This  idea  is  supported  by  the  fact  that
regulators of the pathways were reported to be modulated as
Figure 4. Vimentin protein expression in rat lenses. Vimentin protein level was reduced in the dexamethasone-treated (Dex) group (B)
compared with of the control group (A) and the group treated with both RU486 and Dex (RU486+Dex; C). Magnification 400×.
Figure 5. Reverse transcription polymerase chain reaction (RT–PCR) analysis of vimentinm RNA expression in the rat lens. The expression
of vimentin mRNA was similar in all three groups, suggesting that GR translocation was indirectly involved in the changes in vimentin
observed at the protein level. β-Actin was used as the control for protein loading. C: Control group; D: dexamethasone treated (Dex) group;
R: group treated with both RU486 and Dex (RU486+Dex group).
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37early as 4h and as late as 48h after Dex treatment of lens
epithelial cells [60,65]. Glucocorticoids may be involved in
lens cell function and cataractogenesis through the inhibition
of these signaling pathways.
It is also interesting to note that involvement of both the
PI3K/AKT  and  MAPK  pathways  has  been  reported  for
vimentin expression and activity [68]. Our study shows that
the  vimentin  protein  level  was  reduced  in  the  capsule-
epithelium of the lenses of the Dex group compared with the
control group and the RU486 group, which suggested that
glucocorticoid-GR  mediation  may  lead  to  a  reduction  in
vimentin expression. It is possible that decreased vimentin
expression  may  lead  to  abnormal  lens  epithelial  cell
differentiation, signal transduction, survival, or apoptosis, and
therefore  to  the  formation  of  a  steroid  induced  cataract.
However,  no  differences  were  observed  in  the  mRNA
expression levels in the three groups, which indicated that the
reduced expression of vimentin at the protein level was not
occurring through GR-mediated GRE effects, but probably
was a function of the modulation of the MAPK and PI3K
pathways  via  glucocorticoid-GR  mediation.  Nevertheless,
further evidence is needed to verify exactly where the MARK
and  PI3K/AKT  pathways  come  into  play  in  the  cataract
formation in lens epithelial cells.
In summary, we have demonstrated that the development
of opacity induced by dexamethasone in the rat lens requires
GR-mediated signaling. This opacity may proceed through the
migration of abnormal epithelial cells, which results in the
separation of lens fiber cells. Future study will focus on the
precise mechanisms underlying the GR-mediated reduction in
vimentin by dexamethasone.
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